Nitromint

Active Ingredient:: Glyceryl Trinitrate Solution
Origin:: EU

Nitromint (Glyceryl Trinitrate Solution)

Q: What is Nitromint used for?

Nitromint is prescribed to relieve acute episodes of angina pectoris, to prevent angina attacks when taken before physical exertion, and to manage myocardial ischemia by improving blood flow to the heart muscle.

Q: How does glyceryl trinitrate work?

Glyceryl trinitrate releases nitric oxide in vascular smooth muscle, which activates guanylate cyclase, raising cyclic GMP levels. This cascade relaxes smooth muscle in veins and arteries, lowering cardiac preload and afterload and reducing the heart’s oxygen demand.

Q: What determines the dose of Nitromint?

The dose of Nitromint is individualized by the prescribing clinician based on the severity of the patient’s angina, response to therapy, and any concomitant medications. No fixed dosing regimen is provided here.

Q: Is Nitromint safe during pregnancy or breastfeeding?

Safety data for Nitromint in pregnancy and lactation are limited, and the pregnancy category is listed as unknown. It should be used only if the potential benefit justifies the potential risk to the fetus or infant.

Q: How do I order Nitromint from GNH India?

To request Nitromint, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Q: How does Nitromint compare with other anti‑anginal drugs?

Nitromint belongs to the organic nitrate class, providing rapid vasodilation. Compared with beta‑blockers or calcium‑channel blockers, nitrates act quickly to relieve chest pain but may cause headaches and require avoidance of PDE‑5 inhibitors. Choice of therapy depends on patient profile and clinical goals.

Q: What are the recommended storage conditions for Nitromint?

Nitromint should be stored at room temperature, preferably below 25 °C, in its original container. Keep the bottle tightly closed, protect it from light and moisture, and store out of reach of children.

Q: How is Nitromint administered?

Nitromint is a sublingual solution. The patient places the prescribed number of drops under the tongue, allows it to dissolve completely, and avoids swallowing or drinking for at least one minute to ensure optimal absorption.

Q: What are the most serious risks associated with Nitromint?

The most serious risks include severe hypotension that can lead to syncope, myocardial infarction in rare cases, allergic reactions such as rash or breathing difficulty, and methemoglobinemia, a rare blood disorder causing reduced oxygen delivery.

Q: Who should not use Nitromint?

Nitromint should not be used by patients with severe hypotension, recent use of phosphodiesterase‑5 inhibitors, known hypersensitivity to nitrates, or those with certain cardiovascular instabilities unless specifically directed by a physician.

Glyceryl trinitrate, the active ingredient in Nitromint, is a organic nitrate presented as a sublingual solution for sublingual use. It treats acute angina pectoris, helps prevent angina attacks, and manages myocardial ischemia in adult patients.

GNH India supplies Nitromint as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Egis Pharmaceuticals Plc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nitromint, an organic nitrate, is used in the management of coronary artery disease and related angina syndromes.

Acute angina pectoris: rapid relief of chest pain by dilating coronary vessels.
Prophylaxis of angina attacks: reduces frequency of episodes when taken before exertion.
Management of myocardial ischemia: improves oxygen supply to heart muscle during ischemic episodes.

How It Works

Glyceryl trinitrate is metabolized to nitric oxide in vascular smooth muscle. The released nitric oxide activates soluble guanylate cyclase, increasing cyclic GMP levels, which leads to relaxation of smooth muscle in veins and arteries. Venous dilation reduces preload, while arterial dilation lowers afterload, decreasing myocardial oxygen demand and improving coronary blood flow.

Side Effects

Nitromint may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

Headache: throbbing pain often occurring shortly after administration.
Flushing: warmth and redness of the face and neck.
Dizziness: light‑headed sensation, especially when standing quickly.
Hypotension: drop in blood pressure causing faintness.
Tachycardia: compensatory increase in heart rate.
Nausea: feeling of sickness or urge to vomit.

Serious or Rare Side Effects

Severe hypotension: marked drop in blood pressure leading to syncope.
Syncope: sudden loss of consciousness.
Myocardial infarction: rare worsening of heart attack.
Allergic reaction: rash, itching, swelling, or difficulty breathing.
Methemoglobinemia: abnormal hemoglobin causing cyanosis.
Vision disturbances: blurred vision or visual loss.

Precautions & Warnings

Before prescribing Nitromint, consider the following precautions to ensure safe use.

Severe hypotension: avoid use in patients with systolic BP <90 mmHg.
Phosphodiesterase‑5 inhibitors: do not co‑administer with sildenafil, tadalafil or vardenafil.
Concomitant nitrates: avoid simultaneous use of other nitrate preparations.
Cardiovascular instability: monitor patients with recent myocardial infarction or unstable angina.
Headache management: advise use of analgesics if severe headache occurs.
Store at room temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Nitromint can interact with several drug classes; some require avoidance while others need careful monitoring.

Major Interactions (Avoid)

Sildenafil, tadalafil, vardenafil: risk of profound hypotension.
Other nitrate medications: additive vasodilatory effect leading to severe hypotension.
Isosorbide dinitrate: combined nitrate therapy may cause excessive blood pressure drop.

Moderate Interactions (Monitor Closely)

Beta‑blockers: may mask tachycardia response to hypotension.
Diuretics: can enhance hypotensive effect.
Alcohol: may increase vasodilation and dizziness.
Antihypertensives (e.g., ACE inhibitors, calcium channel blockers): may require dose adjustment.

Frequently Asked Questions

Nitromint is prescribed to relieve acute episodes of angina pectoris, to prevent angina attacks when taken before physical exertion, and to manage myocardial ischemia by improving blood flow to the heart muscle.

Glyceryl trinitrate releases nitric oxide in vascular smooth muscle, which activates guanylate cyclase, raising cyclic GMP levels. This cascade relaxes smooth muscle in veins and arteries, lowering cardiac preload and afterload and reducing the heart’s oxygen demand.

The dose of Nitromint is individualized by the prescribing clinician based on the severity of the patient’s angina, response to therapy, and any concomitant medications. No fixed dosing regimen is provided here.

Safety data for Nitromint in pregnancy and lactation are limited, and the pregnancy category is listed as unknown. It should be used only if the potential benefit justifies the potential risk to the fetus or infant.

To request Nitromint, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Nitromint belongs to the organic nitrate class, providing rapid vasodilation. Compared with beta‑blockers or calcium‑channel blockers, nitrates act quickly to relieve chest pain but may cause headaches and require avoidance of PDE‑5 inhibitors. Choice of therapy depends on patient profile and clinical goals.

Nitromint should be stored at room temperature, preferably below 25 °C, in its original container. Keep the bottle tightly closed, protect it from light and moisture, and store out of reach of children.

Nitromint is a sublingual solution. The patient places the prescribed number of drops under the tongue, allows it to dissolve completely, and avoids swallowing or drinking for at least one minute to ensure optimal absorption.

The most serious risks include severe hypotension that can lead to syncope, myocardial infarction in rare cases, allergic reactions such as rash or breathing difficulty, and methemoglobinemia, a rare blood disorder causing reduced oxygen delivery.

Nitromint should not be used by patients with severe hypotension, recent use of phosphodiesterase‑5 inhibitors, known hypersensitivity to nitrates, or those with certain cardiovascular instabilities unless specifically directed by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 27 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.